MET and colorectal carcinoma: Similarly in another study, researchers identified a heterogeneous pattern of genomic alterations in ctDNA of patients with metastatic CRC including mutations in BRAF, KRAS, NRAS, MAP2K1, PIK3CA, ERBB2, MET, and EGFR genes (19).